Markets:

Overview

News

Currencies

International

Treasuries

Akebia Therapeutics, Inc. - Common Stock (NQ:AKBA)

1.410 -0.040 (-2.76%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Akebia Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 19, 2025

Via Benzinga

Hallador Energy, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

March 18, 2025

Via Benzinga

Top movers analysis one hour before the close of the markets on 2025-03-14: top gainers and losers in today's session. ↗

March 14, 2025

Stay up-to-date with the latest market trends one hour before the close of the markets on Friday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

Recap: Akebia Therapeutics Q4 Earnings ↗

March 14, 2024

Via Benzinga

Earnings Preview For Akebia Therapeutics ↗

March 13, 2024

Via Benzinga

Earnings Outlook For Akebia Therapeutics ↗

November 07, 2023

Via Benzinga

Which stocks are experiencing notable movement on Friday? ↗

March 14, 2025

Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 14, 2025

Via Benzinga

Semtech Posts Better-Than-Expected Earnings, Joins Rubrik, DocuSign, PagerDuty And Other Big Stocks Moving Higher On Friday ↗

March 14, 2025

Via Benzinga

Earnings Scheduled For March 13, 2025 ↗

March 13, 2025

Via Benzinga

AKBA Stock Earnings: Akebia Therapeutics Misses EPS, Misses Revenue for Q1 2024 ↗

May 09, 2024

AKBA stock results show that Akebia Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 10, 2024

Via Benzinga

Akebia Therapeutics Surges on FDA Approval for Anemia Treatment

April 03, 2024

Akebia Therapeutics Inc. (NASDAQ: AKBA) is a biopharmaceutical company specializing in developing treatments for chronic kidney diseases (CKD) and anemia

Via MarketBeat

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 29, 2024

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

March 28, 2024

Via Benzinga

Akebia Therapeutics Inc. (NASDAQ: AKBA) is One of Thursday Morning’s Most Active Stocks

March 28, 2024

Via Investor Brand Network

FDA Approves For Akebia Therapeutics' Vafseo For Kidney Disease Associated Anemia ↗

March 28, 2024

The FDA-approved Vafseo tablets by Akebia Therapeutics for managing anemia in adult dialysis patients with chronic kidney disease. Learn about its once-daily oral HIF-PH inhibitor and global approval...

Via Benzinga

Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket ↗

March 28, 2024

Shares of RH (NYSE: RH) rose sharply in today’s pre-market trading following the release of quarterly results.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 28, 2024

Via Benzinga

Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday ↗

March 27, 2024

U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday.

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 15, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 15, 2024

Via Benzinga

Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 26, 2024

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

March 15, 2024

It's time to start the final day of trading this week with a look into the biggest pre-market stock movers for Friday morning!

Via InvestorPlace

AKBA Stock Earnings: Akebia Therapeutics Beats Revenue for Q4 2023 ↗

March 14, 2024

AKBA stock results show that Akebia Therapeutics beat on revenue for the fourth quarter of 2023.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 14, 2024

Via Benzinga

Earnings Scheduled For March 14, 2024 ↗

March 14, 2024

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.

Via Benzinga

Analyst Highly Confident In Akebia Therapeutics' Kidney Disease-Associated Anemia Drug, Stock Soars ↗

August 28, 2023

HC Wainwright has upgraded Akebia Therapeutics Inc (NASDAQ: AKBA) from Neutral to Buy rat

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 28, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023 ↗

August 28, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Akebia Therapeutics, Inc. - Common Stock (NQ:AKBA)

All News about Akebia Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today